approval
savePADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
community read0 votes
Sponsor: ASTELLAS. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalNov 21, 2025 · 317d ago
- approvalPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalDec 15, 2023 · 1024d ago
- approvalPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalDec 15, 2023 · 1024d ago
- approvalPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalApr 18, 2023 · 1265d ago
- approvalPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalApr 3, 2023 · 1280d ago
- approvalPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalApr 3, 2023 · 1280d ago
- approvalPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalOct 28, 2022 · 1437d ago
- approvalPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalJul 9, 2021 · 1913d ago
same company · ±60 days · 5
- approvalavacincaptad pegol sodium: IZERVAY (AVACINCAPTAD PEGOL SODIUM) — FDA approvalFeb 12, 2025
- approvalenzalutamide: XTANDI (ENZALUTAMIDE) — FDA approvalMar 21, 2025
- approvalenzalutamide: XTANDI (ENZALUTAMIDE) — FDA approvalMar 21, 2025
- approvalenzalutamide: XTANDI (ENZALUTAMIDE) — FDA approvalJan 22, 2025
- approvalenzalutamide: XTANDI (ENZALUTAMIDE) — FDA approvalJan 22, 2025
comments(0)
5-min edit window · permanent after that